How does lifestyle intervention affect depressive symptoms? Results from the Finnish Diabetes Prevention Study

Diabetic Medicine

Volumn 29, Issue 7, 2012, Pages

  Ruusunen, A ^a   Voutilainen, S ^a   Karhunen, L ^a   Lehto, S M ^b   Tolmunen, T ^b   Keinanen Kiukaanniemi S ^c,d,e   Eriksson, J ^f,g,h,i,j   Tuomilehto, J ^j,k,l   Uusitupa, M ^a   Lindstrom J ^j  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF OULU   (Finland)

^d OULU UNIVERSITY HOSPITAL   (Finland)

^e Health Centre of Oulu   (Finland)

^f UNIVERSITY OF HELSINKI   (Finland)

^g HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^h FOLKHÄLSAN RESEARCH CENTER   (Finland)

ⁱ VAASA CENTRAL HOSPITAL   (Finland)

^j NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^k SOUTH OSTROBOTHNIA CENTRAL HOSPITAL   (Finland)

^l DANUBE UNIVERSITY KREMS   (Austria)

more..

Author keywords

Depression; Diet; Intervention; Mental health; Nutrition

Indexed keywords

ANTIDEPRESSANT AGENT;

ADULT; AGED; ARTICLE; BECK DEPRESSION INVENTORY; CALORIC INTAKE; CONTROLLED STUDY; DEPRESSION; FEMALE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL; WEIGHT CHANGE;

ADULT; COUNSELING; DEPRESSION; DIABETES MELLITUS, TYPE 2; DIET; EXERCISE; FEMALE; FINLAND; FOLLOW-UP STUDIES; GLUCOSE INTOLERANCE; HUMANS; INDIVIDUALIZED MEDICINE; LIFE STYLE; MALE; MIDDLE AGED; OBESITY; OUTCOME ASSESSMENT (HEALTH CARE); PRIMARY PREVENTION; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; WEIGHT LOSS;

EID: 84862654168     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2012.03602.x     Document Type: Article

References (30)

1. Mead GE, Morley W, Campbell P, Greig CA, McMurdo M, Lawlor DA. Exercise for depression. Cochrane Database Syst Rev 2009; 3: CD004366.
2. Lin P-Y, Su K-P. A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids. J Clin Psychiatry 2007; 68: 1056-1061.
3. Morris DW, Trivedi MH, Rush AJ. Folate and unipolar depression. J Altern Complement Med 2008; 14: 277-285.
4. Tolmunen T, Hintikka J, Ruusunen A, Voutilainen S, Tanskanen A, Valkonen VP et al. Dietary folate and the risk of depression in Finnish middle-aged men. A prospective follow-up study. Psychother Psychosom 2004; 73: 334-339.
5. Sanchez-Villegas A, Doreste J, Schlatter J, Pla J, Bes-Rastrollo M, Martinez-Gonzalez M. Association between folate, vitamin B6 and vitamin B12 intake and depression in the SUN cohort study. J Hum Nutr Diet 2009; 22: 122-133.
6. Diabetes Prevention Program Research Group. Depression symptoms and antidepressant medicine use in Diabetes Prevention Program participants. Diabetes Care 2005; 28: 830-836.
7. Williamson DA, Rejeski J, Lang W, Van Dorsten B, Fabricatore AN, Toledo K; Look AHEAD Research Group. Impact of a weight management program on health-related quality of life in overweight adults with type2 diabetes. Arch Intern Med 2009; 169: 163-171.
8. Thomson RL, Buckley JD, Lim SS, Noakes M, Clifton PM, Norman RJ et al. Lifestyle management improves quality of life and depression in overweight and obese women with polycystic ovary symdrome. Fertil Steril 2010; 94: 1812-1816.
9. Eriksson J, Lindstrom J, Valle T, Aunola S, Hämäläinen H, Ilanne-Parikka P et al. Prevention of typeII diabetes in subjects with impaired glucose tolerance: the Diabetes Prevention Study (DPS) in Finland. Study design and 1-year interim report on the feasibility of the lifestyle intervention programme. Diabetologia 1999; 42: 793-801.
10. Lindström J, Louheranta A, Mannelin M, Rastas M, Salminen V, Eriksson J et al., Finnish Diabetes Prevention Study Group. The Finnish Diabetes Prevention Study (DPS): lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care 2003; 26: 3230-3236.
11. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P et al. Prevention of type2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343-1350.
12. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 561-571.
13. Lakka TA, Salonen JT. Intra-person variability of various physical activity assessments in the Kuopio Ischaemic Heart Disease Risk Factor Study. Int J Epidemiol 1992; 21: 467-472.
14. Pereira MA, FitzerGerald SJ, Gregg EW, Joswiak ML, Ryan WJ, Suminski RR et al. A collection of Physical Activity Questionnaires for health-related research. Med Sci Sports Exerc 1997; 6: S1-S205.
15. Rubin RR, Ma Y, Marrero DG, Peyrot M, Barrett-Connor EL, Kahn SE et al. Elevated depression symptoms, antidepressant medicine use, and risk of developing diabetes during the Diabetes Prevention Program. Diabetes Care 2008; 31: 420-426.
16. Atlantis E, Baker M. Obesity effects on depression: systematic review of epidemiological studies. Int J Obes (Lond) 2008; 32: 881-891.
17. Herva A, Laitinen J, Miettunen J, Veijola J, Karvonen JT, Laksy K et al. Obesity and depression: results from the longitudinal Northern Finland 1966 Birth Cohort Study. Int J Obes (Lond) 2006; 30: 520-527.
18. Luppino FS, de Wit LM, Bouvy PF, Stijnen T, Cuijpers P, Penninx BW et al. Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry 2010; 67: 220-229.
19. Uusitupa M, Peltonen M, Lindström J, Aunola S, Ilanne-Parikka P, Keinänen-Kiukaanniemi S et al. Ten-year mortality and cardiovascular morbidity in the Finnish Diabetes Prevention Study -secondary analysis of the randomized trial. PLoS One 2009; 4: e5656.
20. Braunholtz DA, Edwards SJ, Lilford RJ. Are randomized clinical trials good for us (in the short term)? Evidence for a 'trial effect'. J Clin Epidemiol 2001; 54: 217-224.
21. Lindström J, Eriksson JG, Valle TT, Aunola S, Cepaitis Z, Hakumäki M et al. Prevention of diabetes mellitus in subjects with impaired glucose tolerance in the Finnish Diabetes Prevention Study: results from a randomized clinical trial. J Am Soc Nephrol 2003; 14: 108-113.
22. Knoll M, Twisk J, Beekman A, Heine RJ, Snoek FJ, Pouwer F. Depression as a risk factor for the onset of type2 diabetes mellitus. A meta-analysis. Diabetologia 2006; 49: 837-845.
23. Golden SH, Lazo M, Carnethon M, Bertoni AG, Schreiner PJ, Diez Roux AV et al. Examining a bidirectional association between depressive symptoms and diabetes. J Am Med Assoc 2008; 299: 2751-2759.
24. Mezuk B, Eaton WW, Albrecht S, Golden SH. Depression and type2 diabetes over the lifespan: a meta-analysis. Diabetes Care 2008; 31: 2383-2390.
25. Finnish Medicines Agency Fimea and Social Insurance Institution. Finnish Statistics on Medicines 2009. Helsinki: Finnish Medicines Agency Fimea and Social Insurance Institution, 2010. Available at Last accessed 14 November 2011.
26. Lindström J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson JG, Hemiö K et al., Finnish Diabetes Prevention Study Group Sustained reduction in the incidence of type2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet 2006; 368: 1673-1679.
27. Beck AT, Steer RA, Garbin MG. Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation. Clin Psychol Rev 1988; 8: 77-100.
28. Raitasalo R. Depressio ja sen yhteys psykoterapian tarpeeseen (Depression and its connections with the need for psychotherapy). Kansaneläkelaitoksen julkaisuja. Vammalan kirjapaino, Vammala 1977; A:13.
29. Veerman JL, Dowrick C, Ayuso-Mateos JL, Dunn G, Barendregt JJ. Population prevalence of depression and mean Beck Depression Inventory score. Br J Psychiatry 2009; 195: 516-519.
30. Lindeman S, Hämäläinen J, Isometsä E, Kaprio J, Poikolainen K, Heikkinen M et al. The 12-month prevalence and risk factors for major depressive episode in Finland: representative sample of 5993 adults. Acta Psychiatr Scand 2000; 102: 178-184.